OTES 150 mg contains Oteseconazole, a next-generation antifungal medication designed to prevent the recurrence of vulvovaginal candidiasis (RVVC) in eligible women. It is a highly selective tetrazole antifungal that inhibits fungal growth by blocking ergosterol synthesis, a vital component of fungal cell membranes.